Oxcarbazepine clinical trials
Also written Trileptal, Oxtellar XR and SPN-804O.
How each study uses Oxcarbazepine is sorted by a rule, right about nine times in ten. Readers can ask us to read every study one by one.Ask us to read each study
Approvals
The first approval found in each region, with its record
- United States
- 14 Jan 2000 · TRILEPTAL · NDA 021014 (FDA, Drugs@FDA)
- European Union
- Not in EMA's list of EU-wide authorizations
From FDA's Drugs@FDA and Purple Book (through openFDA) and the European Medicines Agency, files of Sept 2026 and 27 Oct 2026. National approvals in Europe and other countries are not included. How this is worked out
How studies write it
Studies that test it under each name
Studies by the year they started
43 studies that test it; most in 2009 (5)
| Year | Studies |
|---|---|
| 2001 | 1 |
| 2002 | 3 |
| 2003 | 2 |
| 2004 | 4 |
| 2005 | 4 |
| 2006 | 4 |
| 2008 | 2 |
| 2009 | 5 |
| 2010 | 1 |
| 2011 | 1 |
| 2012 | 1 |
| 2013 | 2 |
| 2014 | 2 |
| 2015 | 2 |
| 2016 | 1 |
| 2017 | 1 |
| 2018 | 2 |
| 2021 | 2 |
| 2024 | 1 |
| 2025 | 1 |
| 2026 | 1 |
By phase
A phase 1/2 study counts in both.
What it is tested for
Each study’s main condition, where its own words name it, so a study counts once.
Who runs them
Industry 23 · Other 20
Roxane Laboratories (5) · Novartis (4) · Supernus Pharmaceuticals, Inc. (3) · Novartis Pharmaceuticals (3) · Teva Pharmaceuticals USA (2) · All India Institute of Medical Sciences, Bhubaneswar (2) · Bial - Portela C S.A. (2) · Ranbaxy Laboratories Limited (2)
Often tested with
Tested in the same studies.
Carbamazepine (5) · Levetiracetam (4) · Valproic Acid (4) · Lamotrigine (4) · Topiramate (3) · Gabapentin (3) · Zonisamide (2) · Phenytoin (2)
Studies
Open first, then newest update. How each study uses Oxcarbazepine is read from its arms, and is right about nine times in ten. Ask us to read each study. These are the studies that list it as an intervention; a search of ClinicalTrials.gov also finds studies that mention it only in a description, such as earlier treatment.
Testing it · 43
- Gabapentin and Oxcarbazepine for Chronic Neuropathic Pain in Children and Adolescents: A Clinical Effectiveness StudyWithdrawnPhase 3Boston Children's HospitalNCT02219373Written as OxcarbazepineHow we know
- Comparison b/w Carbamazepine vs Oxcarbazepine in Treatment of Trigeminal NeuralgiaActive, not recruitingNot applicableAbbasi Shaheed HospitalNCT07252453Written as oxcarbazepineHow we know
- Low vs. Standard Daily Doses of Antiepileptic Drugs in Newly Diagnosed, Previously Untreated Epilepsy(STANDLOW)CompletedPhase 4Mario Negri Institute for Pharmacological ResearchNCT03689114Written as Low dose oxcarbazepineHow we know
- Comparison of Oxcarbazepine Versus Carbamazepine in the Management of Trigeminal NeuralgiaActive, not recruitingPhase 4Jinnah Postgraduate Medical CentreNCT06849219Written as OxcarbazepineHow we know
- Oxcarbazepine 600 mg Tablets Under Fasting ConditionsCompletedPhase 1Teva Pharmaceuticals USANCT00850174Written as OxcarbazepineHow we know
- Oxcarbazepine 600 mg Tablets Under Non-Fasting ConditionsCompletedPhase 1Teva Pharmaceuticals USANCT00849797Written as OxcarbazepineHow we know
- The Efficacy and Safety of Oral Oxcarbazepine 300-1200 mg/Day as Adjuvant Therapy in the Treatment of Bipolar Disorder I or II This Study is Not Being Conducted in the United States.CompletedPhase 4NovartisNCT00154323Written as OxcarbazepineHow we know
- Comparision Efficacy of Carbamazepine & Oxcarbazepine in the Treatment of Trigeminal Neuralgia- a Randomised Clinical TrialStatus unknownPhase 4Postgraduate Institute of Dental Sciences RohtakNCT04996199Written as OxcarbazepineHow we know
- Oxcarbazepine Versus Placebo in Childhood AutismCompletedNot applicableUniversity of Medicine and Dentistry of New JerseyNCT00467753Written as OxcarbazepineHow we know
- A Study in Participants With Epilepsy, to Evaluate the Pharmacokinetics, Safety and Tolerability of Oxcarbazepine on PadsevonilCompletedPhase 1UCB Biopharma S.P.R.L.NCT03695094Written as OxcarbazepineHow we know
- Characterization of Epilepsy Patients BEEP 2bCompletedPhase 1Food and Drug Administration (FDA)NCT02707965Written as Oxcarbazepine (brand name vs generic drugs)How we know
- Long-term Safety and Tolerability of TRI476 (Oxcarbazepine) in Children With Inadequately Controlled Partial Onset SeizuresCompletedPhase 2/3NobelpharmaNCT01051193Written as OxcarbazepineHow we know
- Oxtellar Extended Release (Oxcarbazepine Extended Release) Patients With Trigeminal NeuralgiaWithdrawnPhase 4University of Colorado, DenverNCT03374709Written as Oxtellar XR 150Mg Extended Release TabletHow we know
- Effect of Oxcarbazepine on Serum Brain Derived Neurotrophic Factor (BDNF) in Bipolar DisorderCompletedPhase 4All India Institute of Medical Sciences, BhubaneswarNCT02456896Written as OxcarbazepineHow we know
- Protective Role of Oxcarbazepine in Multiple SclerosisCompletedPhase 2Queen Mary University of LondonNCT02104661Written as OxcarbazepineHow we know
- Pharmacovigilance in Gerontopsychiatric PatientsTerminatedPhase 3Hannover Medical SchoolNCT02374567Written as OxcarbazepineHow we know
- Crossover Bioequivalence Study of Oxcarbazepine 600 mg Suspension Under Fed ConditionsCompletedPhase 1Roxane LaboratoriesNCT01703468Written as OxcarbazepineHow we know
- Bioequivalency Study of Oxcarbazepine 600 mg Tablets Under Fed ConditionsCompletedNot applicableRoxane LaboratoriesNCT00616863Written as OxcarbazepineHow we know
- Bioequivalency Study of 600 mg Oxcarbazepine Tablets Under Fasting ConditionsCompletedNot applicableRoxane LaboratoriesNCT00616681Written as OxcarbazepineHow we know
- Bioequivalency Study of Oxcarbazepine 600 mg Tablets Under Fed ConditionsCompletedNot applicableRoxane LaboratoriesNCT00618046Written as OxcarbazepineHow we know
See all 43 studies that test Oxcarbazepine →
Given beside what is tested · 1 — Oxcarbazepine is usual care or a partner of the new treatment
As the comparator · 2 — what is tested is compared with Oxcarbazepine
- The Benefit and Safety of Older Generation Anti-Epileptic Drugs (AEDs) in Drug-Resistant Epilepsy ChildrenStatus unknownPhase 4Dr Cipto Mangunkusumo General HospitalNCT05697614Written as OxcarbazepineHow we know
- Levetiracetam Versus Oxcarbazepine as Monotherapy to Evaluate Efficacy and Safety in Subjects With Newly or Recently Diagnosed Partial EpilepsyCompletedPhase 4Korea UCB Co., Ltd.NCT01498822Written as OxcarbazepineHow we know
Codes
What other systems call Oxcarbazepine · ClinicalTrials.gg INT006829
- MeSH (NLM) D000078330OxcarbazepineConfirmed ClinicalTrials.gov, NLM, Wikidata
- UNII (FDA) VZI5B1W380OXCARBAZEPINEConfirmed FDA, NLM, Wikidata
- RxNorm 32624Confirmed FDA, Wikidata
- Wikidata Q176301oxcarbazepineConfirmed FDA, NLM, Wikidata
- NCI Thesaurus C47643OxcarbazepineOne source FDA
- DrugBank DB00776One source Wikidata
| System | Code | Name there | Checked by |
|---|---|---|---|
| MeSH (NLM) | D000078330 | Oxcarbazepine | Confirmed ClinicalTrials.gov, NLM, Wikidata |
| UNII (FDA) | VZI5B1W380 | OXCARBAZEPINE | Confirmed FDA, NLM, Wikidata |
| RxNorm | 32624 | — | Confirmed FDA, Wikidata |
| Wikidata | Q176301 | oxcarbazepine | Confirmed FDA, NLM, Wikidata |
| NCI Thesaurus | C47643 | Oxcarbazepine | One source FDA |
| DrugBank | DB00776 | — | One source Wikidata |
“Confirmed” means two independent publishers link the code to this drug; “one source”, one does and its name agrees.